Liang C,Feng P,Ku B,et al.Autophagic and tumour suppressor activity of anovel Beclinl-binding proteinUVRAG[J].Nat Cell Biol,2006,8:688-699.
[2]
Jhawer M,Goel S,Wilson AJ,et al.PIK3CA mutation/PTEN expression status predicts response of colon cancer cells to the epidermal growth factor receptor inhibitor cetuximab[J].Cancer Res,2008,68:1 953-1 960.
[3]
O’Brien CA,Pollett A,Gallinger S,et al.A human colon cancer cell capable of initiating tumor growth in immunodeficient mice[J].Nature,2007,445:106-110.
[4]
Bozzi F,Tamborini E,Pilotti S.The CD133expression levels and its role as potential cancer stem cells marker in gastrointestinal stromal tumor[J].Int J Cancer,2012,131:e849-e850.
[5]
Granelli P,Cattaneo M,Ferrero S,et al.SEL1Land squamous cell carcinoma of the esophagus[J].Clin Cancer Res,2004,10:5 857-5 861.
[6]
Sada K,Takano T,Yanagi S,et al.Structure and function of Syk protein-tyrosine kinase[J].Biochem,2001,130(2):177-186.
[7]
Kufe DW.Mucins in cancer:function,prognosis and therapy[J].Nat Rev Cancer,2009,9:874-885.
[8]
Zhang J,Guo X,Chang DY,et al.CD133expression associated with poor prognosis in ovarian cancer[J].Mod Pathol,2012,25:456-464.
[9]
Shi CJ,Cao J,Wang M,et al.CD133(+)gallbladder carcinoma cells,exhibit self-renewal ability and tumorigenicity[J].World J Gastroenterol,2011,17(24):2 965-2 971.
[10]
Yu L,Zhou L,Wu S,et al.Clinicopathological significance of cancer stem cells marked by CD133and KAI1/CD82expression in laryngeal squamous cell carcinoma[J].World J Surg Oncol,2014,12:118.
[11]
Colomba A,Courilleau D,Ramel D,et al.Activation of Rac1and the exchange factor Vav3 are involved in NPM-ALK signaling in anaplastic large cell lymphomas[J].Oncogene,2008,27:2 728-2 736.
[12]
Shan SW,Fang L,Shatseva T,et al.Mature miR-17-5p and passenger miR-17-3p induce hepatocellular carcinoma by targeting PTEN,GalNT7and vimentin in different signal pathways[J].J Cell Sci,2013,126:1 517-1 530.
